Dry Eye Syndrome Market Global Scenario, Market Size, Outlook, Trend Dry Eye Syndrome Market Global Scenario | Page 3

VARIANT MARKET RESEARCH
into nutritional supplement, serum eye drops, lubricant eye drops (oily tear eye drops, ointments and preservative-free
drops) and anti-inflammatory drugs (Tetracyclines and Corticosteroids).
By geography the market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The
U.S., Canada and Mexico are covered under North America wherein Europe covers U.K., Germany, France, and others.
Asia-Pacific covers India, China, Japan and others. RoW covers South America, Middle East and Africa.
Some of the major companies in global Dye Eye Syndrome market are Allergan, Alcon (a wholly-owned subsidiary of
Novartis), Santen Pharmaceutical, Shire/SAR code Bioscience, Otsuka Holdings, Can-Fete Biopharma, Novartis, and
Exegete Pharma among others.
The key takeaways from the report
•
The report will provide detailed analysis of Dry Eye Syndrome Market with respect to major
segments such as type, treatment type and geography
•
The report will include the qualitative and quantitative analysis with market estimation over
2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024
•
Comprehensive analysis of market dynamics including factors and opportunities will be
included in the report
• An exhaustive regional analysis of Dry Eye Syndrome Market has been provided in the report
• Profile of the key players in the Dry Eye Syndrome Market will be provided, which include key
financials, product & services, new developments and business strategies
Scope of Dry Eye Syndrome Market
Type Segments
• Evaporative Dry Eye
• Aqueous Dry Eye
Treatment Type Segments
• Nutritional Supplements
• Serum Eye Drops
• Lubricant Eye Drops
o Oily Tear Eye Drops
o Ointments
~ 3 ~